The TRANSBIO clinical study has started with inclusion of the first patient in the Hospital Puerta de Hierro (Madrid, Spain) on the 12th of June 2018, with Dr. José María Portoles as Principal Investigator. The University Hospital Puerta de Hierro was created in 1964 and it is a general hospital of first level that fulfils a triple function: [...]
Biohope is holding these days meetings in Boston with investors and companies for future collaborations in the development of the Inmunobiogram®, cutting-edge technology in the treatment of chronic inflammatory diseases that will allow the personalization of immunosuppressive therapy, selecting the drugs and the most appropriate doses. > We were in BIO International Convention > [...]
Dra. Isabel Portero, Biohope´s CEO, has been included in the list of “100 Most Creative People in Business” published by Forbes. […]
The 2018 Biotech Investment showcase is the UK and Europe’s most focussed and leading-edge funding, investment and partnering forum in the biotech sector, hosting over 200 attendees. Biope will be at this important event on the 22nd & 23rd May 2018 in London presenting the company to biotechnology investors. Leading VC funds, investors, hedge [...]